Ultracare Anesthetic Gel
Product Images NDC 10129-072

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Ultracare Anesthetic Gel (NDC 10129-072). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by The Belport Company, Inc. Dba Gingi-pak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Benzocaine 20% W/v (Api)

A partial drug facts panel showing the active ingredient as Benzocaine 20% w/v and its purpose listed as Oral Anesthetic.*

FDA Label Image

Alert (Allergy Alert)

Text panel displaying an allergy alert for UltraCare Anesthetic Gel (Benzocaine), warning against use in patients with a history of allergies to any 'caine' local anesthetics or FD&C Red #40 and advising to avoid contact with sensitive areas.*

FDA Label Image

Keep Out Of Reach Of Children (Children)

Drug facts text panel containing safety warning 'Keep out of reach of children.' The text is in bold and black font on a white background.*

FDA Label Image

Consult (Consult)

Text panel advising consumers to consult a doctor or pharmacist before use if experiencing specific conditions such as severely traumatized or infected mucosal areas or posterior pharynx issues. It also instructs to stop use and seek medical advice if symptoms like sore throat lasting more than two days, fever, headache, rash, nausea, vomiting, persistent mouth sores, or worsening irritation, pain, or redness occur.*

FDA Label Image

Do Not Use In Patients With History Of Ypersensitivity To Any Ester-type Local Anesthetics. Do Not Use The Product For Teething Or In Infants And Children Younger Than 2 Years (Dnu)

This text panel contains a warning advising against the use of UltraCare Anesthetic Gel in patients with a history of hypersensitivity to ester-type local anesthetics. It also warns against use in infants and children younger than 2 years and for teething.*

FDA Label Image

Dnu (Dnu2)

Text panel showing a usage caution stating 'DO NOT USE IF TAMPER-EVIDENT SLEEVE IS BROKEN.' This warning advises against using the product if the tamper-evident seal is damaged.*

FDA Label Image

Dose Admin (Doseadmin)

A drug facts panel titled Dosage & Administration for UltraCare Anesthetic Gel, describing instructions for drying mucosa before application, use of sterile cotton or gauze for applying, cautions to avoid cross-contamination, dosage limits, usage frequency, and age-related guidance for adults, children 2 years and older, and children under 2 years.*

FDA Label Image

Facts (Drugfacts1)

Drug Facts warnings and other information panel for UltraCare Anesthetic Gel containing benzocaine. The panel includes warnings about methemoglobinemia risk, instructions to ask a doctor or pharmacist before use if certain conditions apply, and directions to stop use and ask a doctor if symptoms worsen. It lists inactive ingredients, storage instructions, tamper-evident packaging information, and contact information for questions or comments.*

FDA Label Image

Facts (Drugfacts2)

Drug Facts panel for UltraCare Anesthetic Gel containing 20% benzocaine as the active ingredient. It includes sections on purpose, uses to reduce oral pain or discomfort, directions for topical application, dosage instructions, warnings against use in hypersensitive patients and for children under 2 years, and allergy alerts. The text advises to consult a doctor or dentist for prolonged use or specific age groups.*

FDA Label Image

Inactive (Inactive)

This image shows a list of inactive ingredients including Polyethylene Glycol 400 NF, Polyethylene Glycol 3350 (3550) NF, Sodium Saccharin, artificial flavor, and FD&C Red #40.*

FDA Label Image

Reduce Pain Or Discomfort Caused By Minor Dental Procedures • Minor Gum Injury • Canker Sores • Sore Throat • Minor Mouth Or Gum Irritations Caused By Dentures Or Orthodontic Appliances. (Intended Use)

Text panel excerpt from UltraCare Anesthetic Gel labeling describing its uses and directions. Uses include reducing pain or discomfort from minor dental procedures, gum injury, canker sores, sore throat, and minor mouth or gum irritations. Directions indicate its use for anesthesia of mucous membranes of oropharynx and pain minimization during various procedures and imaging in patients with gag reflex.*

FDA Label Image

Lable (Label)

UltraCare Topical Anesthetic Gel label showing 20% Benzocaine oral anesthetic in a 1 oz (30 g) tube. Manufactured for Ultradent Products Inc., South Jordan, UT. Features a pink and white design with Bubble Gum flavor indicated. Includes contact information for Ultradent Products, Inc.*

FDA Label Image

Storage (Storage)

Text panel excerpt from UltraCare Anesthetic Gel packaging advising to avoid excessive heat above 40 degrees Celsius (104 degrees Fahrenheit) and stating the net content is 1 ounce (30 grams).*

FDA Label Image

Warnings (Warnings)

This text panel contains warnings and precautions for UltraCare Anesthetic Gel containing Benzocaine. It advises against use in patients with ester-type anesthetic hypersensitivity, children under 2 years, and those allergic to local anesthetics or FD&C Red #40. It also warns about methemoglobinemia, outlines symptoms, and instructs to seek medical attention if necessary. The panel emphasizes external use only and keeping the product out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.